Ipsen Group

About Ipsen Group

Ipsen Group is a global biopharmaceutical group dedicated to the development of innovative medicines in the fields of oncology, neuroscience, and rare diseases. Founded in 1929, the company has established a strong presence in over 100 countries, with a commitment to improving patient outcomes through cutting-edge research and development.

With a focus on high-quality products, Ipsen invests significantly in R&D, collaborating with leading academic institutions and industry partners. The company’s portfolio includes a range of therapeutic solutions that address unmet medical needs, particularly in the areas of cancer treatment and neurological disorders.

At Ipsen, we believe in the power of innovation and strive to create value for patients, healthcare professionals, and stakeholders alike. Our mission is to provide access to life-changing therapies while maintaining the highest standards of safety and efficacy.

Our vision is to be a trusted partner in healthcare, recognized for our commitment to scientific excellence and patient-centric approach. We are dedicated to fostering a culture of collaboration, integrity, and respect within our teams and with our partners.

• Core Values: Innovation, Integrity, Collaboration, and Patient Focus.
• Headquarters: Located in the UK, Ipsen operates globally with a diverse workforce committed to making a difference.
• Community Engagement: Ipsen actively participates in initiatives that support health education and access to care in underserved communities.

As we look to the future, Ipsen Group remains steadfast in our commitment to advancing science and improving lives, ensuring that we continue to meet the evolving needs of patients and healthcare systems worldwide.